Nachrichten zur ANI Pharmaceuticals Inc. Aktie

Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue

It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, &…

Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO

It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Expand Energy, Avista &…

Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree

HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.…

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript

…

ANI Pharmaceuticals Announces FDA Approval for Expansion of ILUVIEN® Label

BAUDETTE, Minn., March 14, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…

Zacks.com featured highlights include ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone

ANI Pharmaceuticals, Dana, Pitney Bowes, Priority Technology and Kingstone are part of the Zacks Screen of the Week article.…

ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance

BAUDETTE, Minn., Feb. 28, 2025 (GLOBE NEWSWIRE) --  ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…

ANI Pharmaceuticals to Present at Raymond James’ Institutional Investors and Leerink Partners Global Healthcare Conferences in March

PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today…

Are Investors Undervaluing ANI Pharmaceuticals (ANIP) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year?

Here is how ANI Pharmaceuticals (ANIP) and Doximity (DOCS) have performed compared to their sector so far this year.…

ANI Pharmaceuticals: More Than Just A Generics Company

…

ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference

PRINCETON, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today…

NRx Pharmaceuticals, Inc. (NRXP) Q3 2024 Earnings Call Transcript

…

ANI Pharmaceuticals, Inc. (ANIP) Q3 2024 Earnings Call Transcript

…

ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance

BAUDETTE, Minn., Nov. 08, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…

Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript

…

ANI Pharmaceuticals Is Acting Like It Is Being Acquired

…

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.06%

PRINCETON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

Cycle Pharmaceuticals Stands By $488 Million Offer for Vanda

Cycle Pharmaceuticals Ltd. is still interested in acquiring Vanda Pharmaceuticals Inc. after one of Vanda’s drugs failed to receive regulatory…

ANI Pharmaceuticals: A Rare GARP Stock In An Overbought Market

…

Aresus gibt Strategie zur Erweiterung der Produktionskapazitäten für den pharmazeutischen Wirkstoff Sinecatechins bekannt

Dermago GmbH: Strausberg (ots) - Die Aresus Pharma GmbH, ein Unternehmen der DERMAGO-Gruppe, Deutschland, gibt den Abschluss einer Kooperationsvereinbarung mit…

ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences

PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today…

ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences

PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced…

ANI Pharmaceuticals, Alimera Sciences deal set to close Monday

…

ANI Pharmaceuticals and Alimera Sciences Announce Closing Date of Merger

ANI and Alimera Scheduled the Closing for September 16, 2024 ANI and Alimera Scheduled the Closing for September 16, 2024…

ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences

PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today…

NRx Pharmaceuticals, Inc. (NRXP) Q2 2024 Earnings Call Transcript

…

Earnings call: ANI Pharmaceuticals reports strong Q2 growth, raises guidance By Investing.com

Earnings call: ANI Pharmaceuticals reports strong Q2 growth, raises guidance…

ANI Pharmaceuticals, Inc. (ANIP) Q2 2024 Earnings Call Transcript

…

ANI Pharmaceuticals, Inc. Prices Upsized $275.0 Million Convertible Senior Notes Offering

PRINCETON, N.J., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

ANI Pharmaceuticals beats top-line and bottom-line estimates; raises FY24 outlook

…

ANI Pharmaceuticals Reports Second Quarter 2024 Financial Results and Raises 2024 Guidance

BAUDETTE, Minn., Aug. 06, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…

ANI Pharmaceuticals: Tezruly Just Approved, 2 More NDAs Under Review And Alimera Science Acquisition Could Triple Revenue By 2028

…

ALIM ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc.

New York, July 27, 2024 (GLOBE NEWSWIRE) -- NEW YORK, July 27, 2024 / GlobeNewswire/-- Monteverde & Associates…

Nika Pharmaceuticals, Inc. (NIKA) Signed a Distribution Agreement for Nigeria

Nika Pharmaceuticals, Inc. (OTCMKTS: NIKA) signed a distribution agreement for the Republic of Nigeria that can generate the company €7.9…

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. – ALIM

NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has…

ANI Pharmaceuticals Announces the FDA Approval and Launch of Naproxen Delayed-Release Tablets, USP

PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals

Alimera (ALIM) is set to be acquired by ANI Pharmaceuticals for approximately $381 million in upfront consideration. The transaction is…

ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences

Conference call scheduled for today at 8:30 a.m. ET…

Global Bipolar Disorder Market Size To Exceed USD 6.47 Billion By 2033 | CAGR Of 1.98%

The Global Bipolar Disorder Market Size was Valued at USD 5.32 Billion in 2023, the Worldwide Bipolar Disorder Market Size…

Implied Volatility Surging for ANI Pharmaceuticals (ANIP) Stock Options

Investors need to pay close attention to ANI Pharmaceuticals (ANIP) stock based on the movements in the options market lately.…

ANI Pharmaceuticals Is Undervalued, As Royalty Potential Is Overlooked

…

Global Dyspepsia Drugs Market Size To Worth Exceed USD 14.7 Billion By 2033 | CAGR Of 4.46%

The Global Dyspepsia Drugs Market Size was Valued at USD 9.5 Billion in 2023 and the Worldwide Dyspepsia Drugs Market…

ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference

BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today…

NRx Pharmaceuticals, Inc. (NRXP) Q1 2024 Earnings Call Transcript

…

ANI Pharmaceuticals, Inc. (ANIP) Q1 2024 Earnings Call Transcript

…

Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building

Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production…

ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance

BAUDETTE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…

ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: Whats in Store?

ANI Pharmaceuticals (ANIP) revenues in the first quarter of 2024 are likely to have been driven by increased sales of…

ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET

BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today…